Initially, these cells are isolated from homogenized tumors or sentinel lymph nodes and then cultured with IL-2 in the presence of tumor lysate as a source of tumor-antigens and peripheral blood mononuclear cells (PBMC) for efficient antigen presentation [43]. Here, IL2 is linked to neoplasm.